Want to join the conversation?
Medical technology company $BSX said it received CE Mark for its transcatheter aortic valve implantation technology, the LOTUS Edge Valve System. LOTUS is indicated for aortic valve replacement in patients with severe aortic stenosis who are considered at high risk for surgical valve replacement.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.